This is the first randomized , double-blind , placebo-controlled trial ( EUDRACT No. 2009-013923-43 ) evaluating nickel oral hyposensitizing treatment ( NiOHT ) in patients with `` systemic nickel allergy syndrome '' ( SNAS ) , characterized by Ni-allergic contact dermatitis and systemic reactions after eating Ni-rich food .